Microbix Biosystems Statistics
Total Valuation
MBXBF has a market cap or net worth of 24.85 million. The enterprise value is 20.73 million.
Market Cap | 24.85M |
Enterprise Value | 20.73M |
Important Dates
The last earnings date was Monday, August 11, 2025.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 140.03M |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.23% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 117.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.60 |
PB Ratio | 1.16 |
P/TBV Ratio | 1.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | 56.33 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.03, with an EV/FCF ratio of -104.39.
EV / Earnings | -87.02 |
EV / Sales | 1.35 |
EV / EBITDA | 15.03 |
EV / EBIT | 50.08 |
EV / FCF | -104.39 |
Financial Position
The company has a current ratio of 9.73, with a Debt / Equity ratio of 0.22.
Current Ratio | 9.73 |
Quick Ratio | 5.85 |
Debt / Equity | 0.22 |
Debt / EBITDA | 3.37 |
Debt / FCF | -23.65 |
Interest Coverage | 0.61 |
Financial Efficiency
Return on equity (ROE) is -1.13% and return on invested capital (ROIC) is 1.02%.
Return on Equity (ROE) | -1.13% |
Return on Assets (ROA) | 0.94% |
Return on Invested Capital (ROIC) | 1.02% |
Return on Capital Employed (ROCE) | 1.60% |
Revenue Per Employee | 154,964 |
Profits Per Employee | -2,382 |
Employee Count | 100 |
Asset Turnover | 0.56 |
Inventory Turnover | 1.24 |
Taxes
In the past 12 months, MBXBF has paid 110,395 in taxes.
Income Tax | 110,395 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.95% in the last 52 weeks. The beta is 0.24, so MBXBF's price volatility has been lower than the market average.
Beta (5Y) | 0.24 |
52-Week Price Change | -29.95% |
50-Day Moving Average | 0.22 |
200-Day Moving Average | 0.26 |
Relative Strength Index (RSI) | 15.21 |
Average Volume (20 Days) | 62,115 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MBXBF had revenue of 15.50 million and -238,167 in losses. Loss per share was -0.00.
Revenue | 15.50M |
Gross Profit | 8.64M |
Operating Income | 418,869 |
Pretax Income | -127,772 |
Net Income | -238,167 |
EBITDA | 1.26M |
EBIT | 418,869 |
Loss Per Share | -0.00 |
Balance Sheet
The company has 8.87 million in cash and 4.70 million in debt, giving a net cash position of 4.18 million.
Cash & Cash Equivalents | 8.87M |
Total Debt | 4.70M |
Net Cash | 4.18M |
Net Cash Per Share | n/a |
Equity (Book Value) | 21.49M |
Book Value Per Share | 0.15 |
Working Capital | 15.86M |
Cash Flow
In the last 12 months, operating cash flow was 441,168 and capital expenditures -639,714, giving a free cash flow of -198,546.
Operating Cash Flow | 441,168 |
Capital Expenditures | -639,714 |
Free Cash Flow | -198,546 |
FCF Per Share | n/a |
Margins
Gross margin is 55.77%, with operating and profit margins of 2.70% and -1.54%.
Gross Margin | 55.77% |
Operating Margin | 2.70% |
Pretax Margin | -0.82% |
Profit Margin | -1.54% |
EBITDA Margin | 8.14% |
EBIT Margin | 2.70% |
FCF Margin | n/a |
Dividends & Yields
MBXBF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.23% |
Shareholder Yield | n/a |
Earnings Yield | -0.96% |
FCF Yield | -0.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MBXBF has an Altman Z-Score of 3.41 and a Piotroski F-Score of 5.
Altman Z-Score | 3.41 |
Piotroski F-Score | 5 |